Skip to main content
Equibles

RAFFA WEALTH MANAGEMENT, LLC

Position in ZTS — Zoetis Inc.

CIK 1631073 WASHINGTON, DC
Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$7,545
-$3,921 QoQ
Shares Held
105
+8.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,262
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RAFFA WEALTH MANAGEMENT, LLC holds $34,977 across 13 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (21.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 683 $9,896
2 ZTS
Zoetis Inc.
This page 		105 $7,545
3 NBIX
Neurocrine Biosciences Inc
 24 $4,044
4 HLN
Haleon plc
 368 $3,433
5 TAK
Takeda Pharmaceutical Co Ltd
 208 $3,334
6 VTRS
Viatris Inc
 143 $2,270
7 ELAN
Elanco Animal Health Inc
 73 $1,796
8 TEVA
Teva Pharmaceutical Industries Ltd
 38 $1,287

All Filings in ZTS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,545 105
2026-03-31 $11,466 97
2025-12-31 $12,078 96
2025-09-30 $10,827 74
2025-06-30 $10,292 66
2025-03-31 $10,866 66
2024-12-31 $10,753 66
2024-09-30 $13,481 69
2024-06-30 $134,007 773
2024-03-31 $124,200 734
2023-12-31 $13,618 69
2023-09-30 $12,004 69
2023-06-30 $6,716 39
2023-03-31 $6,491 39
2022-12-31 $5,715 39
2022-09-30 $5,783 39
2022-06-30 $6,703 39
2022-03-31 $7,355 39
2021-12-31 $9,517 39
2021-09-30 $7,571 39
2021-06-30 $7,268 39
2021-03-31 $6,141 39
2020-12-31 $5,461 33
2020-09-30 $5,457 33
2020-06-30 $4,522 33
2020-03-31 $3,883 33

Report a Problem

Category
Description
Email (optional, for follow-up)